Effects of Glucagon-Like Peptide-1 on Oxidative Stress and Nrf2 Signaling
Open accessThe DOI matches its Crossref record; 131 of the 133 references it cites were found in a registry or an index.
Abstract
Oxidative cellular damage caused by free radicals is known to contribute to the pathogenesis of various diseases such as cancer, diabetes, and neurodegenerative diseases, as well as to aging. The transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) and Kelch-like ECH-associated protein1 (Keap1) signaling pathways play an important role in preventing stresses including oxidative and inflammatory stresses. Nrf2 is a master regulator of cellular stress responses, induces the expression of antioxidant and detoxification enzymes, and protects against oxidative stress-induced cell damage. Glucagon-like peptide-1 (GLP-1) is an incretin hormone, which was originally found to increase insulin synthesis and secretion. It is now widely accepted that GLP-1 has multiple functions beyond glucose control in various tissues and organs including brain, kidney, and heart. GLP-1 and GLP-1 receptor agonists are known to be effective in many chronic diseases, including diabetes, via antioxidative mechanisms. In this review, we summarize the current knowledge regarding the role of GLP-1 in the protection against oxidative damage and the activation of the Nrf2 signaling pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“dysfunction of endothelial cells, induced by hyperglycemia and driven by this systemic proinflammatory state, trigger cardiomyocyte dysfunction in HFpEF.”
From The cardioprotective effects of semaglutide exceed those of dietary weight loss in mice with HFpEF (2023) · cites this paper as [66]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The Nrf2 signaling pathway, a master regulator of cellular antioxidant defense mechanisms, is upregulated by GLP-1 receptor activation, according to preclinical research (49).”
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Improvements in HF-related symptoms and physical function have been broadly recognized as key goals of care in patients with HFpEF by clinicians, professional societies and regulators. 45”
From Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials (2024) · cites this paper as [45]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Free radicals, metals and antioxidants in oxidative stress-induced cancer
Valko, M., Rhodes, C. J., Moncol, J., Izakovic, M., & Mazur, M. (2006) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2005.12.009 · Cited by 6,680
Oxidative stress, inflammation, and cancer: How are they linked?
Reuter, S., Gupta, S. C., Chaturvedi, M. M., & Aggarwal, B. B. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.09.006 · Cited by 5,441
Biology of Incretins: GLP-1 and GIP
Baggio, L. L., & Drucker, D. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.054 · Cited by 3,639 · cited 2×
“In addition to its actions on the pancreas, GLP-1 reduces glucose production in the liver and increases glucose uptake in adipose tissue and muscle [64,78,79].”
BackgroundCell Survival Responses to Environmental Stresses Via the Keap1-Nrf2-ARE Pathway
Kensler, T. W., Wakabayashi, N., & Biswal, S. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141046 · Cited by 3,630 · cited 2×
“Under basic conditions, Nrf2 is bound to the endogenous inhibitor Kelch-like ECH-associated protein1 (Keap1), which is anchored to actin in the cytoskeleton in the cytosol, and suppressed by Keap1-dependent ubiquitination-proteasomal degradation [8].”
BackgroundThe biology of incretin hormones
Drucker, D. J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.004 · Cited by 2,210 · cited 1×
“GLP-1 has many additional effects; it delays gastric emptying, inhibits food intake, improves insulin sensitivity, inhibits glucagon secretion, and stimulates insulin biosynthesis [18,53].”
BackgroundThe Nrf2 regulatory network provides an interface between redox and intermediary metabolism
Hayes, J. D., & Dinkova-Kostova, A. T. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.02.002 · Cited by 2,141 · cited 2×
“Nrf2–ARE binding regulates the expression of genes involved in cellular antioxidant and anti-inflammatory responses such as superoxide dismutase, catalase, glutathione peroxidases, thioredoxin, thioredoxin reductase, sulfiredoxin, NADPH:quinone oxidoreductase-1, heme oxygenase-1, glutathione reductase, glutaredoxin, g…”
BackgroundAntioxidants Maintain Cellular Redox Homeostasis by Elimination of Reactive Oxygen Species
He, L., He, T., Farrar, S., Ji, L., Liu, T., & Ma, X. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000485089 · Cited by 2,127
Cellular mechanisms and physiological consequences of redox-dependent signalling
Holmström, K. M., & Finkel, T. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3801 · Cited by 2,093
Oxidative stress in Parkinson's disease
Jenner, P. (2003) · Annals of Neurology · doi:10.1002/ana.10483 · Cited by 2,053
Strategies of antioxidant defense
SIES, H. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb18025.x · Cited by 1,976
Cited by
Items 101–200 of 217
Oyetayo, F. L., Akomolafe, S. F., Jegede, F. O., Elekofehinti, O. O., Akinjiyan, M. O., & Odeniyi, I. A. (2021) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-021-00921-0 · Cited by 15
“Reduced antioxidant enzymes activities in diabetic states have also been reported [11].”
BackgroundInfluentialAtrial Fibrillation in Diabetes: Pathogenesis and Targeted Rhythm Control Strategies
Grigoriou, K., Karakasis, P., Pamporis, K., Theofilis, P., Patoulias, D., Karagiannidis, E., Fyntanidou, B., Antoniadis, A. P., & Fragakis, N. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47070559 · Cited by 18
“GLP-1 RAs also bolster antioxidant and anti-apoptotic defenses mediated by activated PKA and Epac signaling pathways [206], diminishing oxidative stress and its fibrotic consequences [207].”
Effect of Docosahexaenoic Acid (DHA) at the Enteric Level in a Synucleinopathy Mouse Model
Lamontagne‐Proulx, J., Coulombe, K., Dahhani, F., Côté, M., Guyaz, C., Tremblay, C., Marzo, V. D., Flamand, N., Calon, F., & Soulet, D. (2021) · Nutrients · doi:10.3390/nu13124218 · Cited by 14
“It is interesting that GLP-1 has been shown to exert an antioxidative action, reducing oxidative stress markers by phosphorylation of Nrf2 [93,94].”
BackgroundCharaya, A., Sahu, C., Singla, S., & Jena, G. (2022) · Biological Trace Element Research · doi:10.1007/s12011-022-03392-3 · Cited by 14
Diabetes mellitus therapy in the light of oxidative stress and cardiovascular complications
Osman, A. A. M., Seres, A. B., & Ducza, E. (2024) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2024.108941 · Cited by 21
Sun, Y., Xu, J., Zou, L., Tan, Y. L., Li, J., Xin, H., Guo, Y., Kong, W., Tian, D., Bao, X., et al. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.101770 · Cited by 13
Yao, M.-Y., Li, L.-Q., Ma, J.-X., Xue, P., & Li, Y.-K. (2020) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20198652 · Cited by 13
Gao, J., Xu, P., Wang, F., Zhang, W., Min, M., Urba, R., & Fan, L. (2024) · Scientific Reports · doi:10.1038/s41598-024-54197-4 · Cited by 17
Wang, W., Liu, M., Miao, H., Gong, X., Han, F., Shi, L., Yan, X., & Xu, Z. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149309 · Cited by 13
Renoprotective Effects of Incretin‐Based Therapy in Diabetes Mellitus
Yaribeygi, H., Atkin, S. L., Montecucco, F., Jamialahmadi, T., & Sahebkar, A. (2021) · BioMed Research International · doi:10.1155/2021/8163153 · Cited by 14
“Antioxidant activity Decrease the levels of LDH, oxLDL, CK-MB, and MDA; induces NRF2 activity and potentiates antioxidant defense system; decreases NOX activity and free radical production, ameliorates oxidative damage [11, 13, 31, 41, 42]”
BackgroundInfluentialPongsuwan, K., Kusirisin, P., Narongkiatikhun, P., Chattipakorn, S. C., & Chattipakorn, N. (2022) · Journal of Cellular Physiology · doi:10.1002/jcp.30891 · Cited by 15
“During ROS exposure, Keap1 is inactivated and allows Nrf2 to activate several genes to produce antioxidants (Oh & Jun, 2017).”
BackgroundSong, B., Lee, S. H., Park, J. H., & Moon, K. C. (2023) · Cancer Research and Treatment · doi:10.4143/crt.2023.577 · Cited by 13
Fang, S., Cai, Y., Li, P., Wu, C., Zou, S., Zhang, Y., Lin, X., & Guan, M. (2019) · Europe PMC (PubMed Central) · doi:10.12122/j.issn.1673-4254.2019.04.13 · Cited by 14
Hong, S. M., Yoon, D. H., Lee, M. K., Lee, J. K., & Kim, S. Y. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/9973678 · Cited by 17
“Numerous studies have already demonstrated that memory impairment in the scopolamine-induced mouse model is correlated with the production of oxidative stresses, such as through reactive oxygen species (ROS) from the brain via the dysfunction of antioxidant enzymes [11].”
BackgroundMani, V., & Arfeen, M. (2024) · Brain Sciences · doi:10.3390/brainsci14121191 · Cited by 12
Alnaser, R. I., Alassaf, F. A., & Abed, M. N. (2024) · Journal of Bone Metabolism · doi:10.11005/jbm.24.739 · Cited by 14
“In 2017, Oh and Jun [76] proposed a GLP-1 anti-oxidative potential, either through an effect on glucose or by activation of Nrf2 signals and enhancement of the anti-oxidant defense system.”
Can glucagon-like peptide-1 receptor agonists induce asthma? An analysis of the FAERS database
Cazzola, M., Matera, M. G., Calzetta, L., Lauro, D., & Rogliani, P. (2024) · Journal of Asthma · doi:10.1080/02770903.2024.2372600 · Cited by 13
“…also affect the function of immune cells involved in asthma pathogenesis, including T lymphocytes, eosinophils, and neutrophils (19), have antioxidant properties (20) and can attenuate oxidative stress-induced airway inflammation, which is implicated in asthma exacerbations and disease progression.”
GLP-1 agonists: a game changer in pain treatment and addiction
Bade, S., Hurdle, M. F. B., Bade, S., Encalada, S., Kanahan-Osman, S., & Gupta, S. (2025) · Pain Management · doi:10.1080/17581869.2025.2536998 · Cited by 12
Khine, H. E. E., Mangmool, S., & Parichatikanond, W. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178233 · Cited by 9
Reduction of hippocampal IL-6 levels in LPS-injected rats following acute exendin-4 treatment
Géa, L. P., da Rosa, E. D., Panizzutti, B., de Aguiar, É. Z., de Oliveira, L. F., Ferrari, P., Piato, Â., Gomez, R., Colombo, R., & Rosa, A. R. (2020) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-020-01867-5 · Cited by 10
“Also, GLP-1 has demonstrated an effect on enhancing antioxidant capacity in various tissues by activating cyclic adenosine monophosphate (cAMP), phosphoinositide 3-kinase (PI3K), and protein kinase C (PKC) (Oh and Jun 2017).”
BackgroundMangiferin Against Respiratory Diseases: Pharmacological Targets and Prospects
Ahmed, K. A., Afrin, N., Ghosh, P., Heya, I. A., Akash, S. R., Moni, A., Islam, M. N., Hossain, M. G., Sinopoli, A., Hannan, M. A., et al. (2025) · Pharmacology Research & Perspectives · doi:10.1002/prp2.70163 · Cited by 7
“NF-κB is mainly triggered by ROS through IκB phosphorylation and aids in the formation of inflammasome complexes [60–62].”
Chaudhry, A., Thompson, D. M., & Chanoine, J. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70240 · Cited by 10
“56,57 This also corresponds to increased mitophagy and improvement in mitochondrial membrane potential, mass and morphological characteristics in various tissues.”
Elsiad, E. A., Aal, H. A. A. E., Salem, H. A., El-Yamany, M. F., & Rabie, M. A. (2025) · Toxics · doi:10.3390/toxics13070594 · Cited by 12
“In opposition, treatment with LIRA, a GLP-1R agonist, alleviated oxidative stress through several molecular pathways as observed herein and previously [24].”
Bulger, D. A., Zhang, Z., Hu, R., Dave, E. K., Mehta, P. K., Griendling, K. K., & Valdivia, A. (2025) · Antioxidants and Redox Signaling · doi:10.1177/15230864251372607 · Cited by 8
Matić, A., Vuković, R., Heffer, M., Balog, M., Ivić, V., Gáspár, R., Ducza, E., Szűcs, K. F., Seres, A. B., Vari, S. G., et al. (2021) · Croatian Medical Journal · doi:10.3325/cmj.2021.62.215 · Cited by 7
“These processes increase the antioxidant capacity or antioxidative enzymes expression in tissues, the parameters that are often altered in diabetes (18,19).”
BackgroundPhysiology and pharmacology of glucagon-like peptide-1 receptor
Куркин, Д. В., Bakulin, D. A., Morkovin, E. I., Petrov, V. I., Strygin, A. V., Koryanova, K. N., Gorbunova, Y. V., Kolosov, Y. A., Ivanova, O. V., Pavlova, E. V., et al. (2024) · Pharmacy & Pharmacology · doi:10.19163/2307-9266-2023-11-4-347-380 · Cited by 13
Parkinson’s disease and brain insulin signaling: Mechanisms and potential role of GLP-1 mimetics
Foroozanmehr, B., Hemmati, M. A., Yaribeygi, H., Karav, S., Jamialahmadi, T., & Sahebkar, A. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149738 · Cited by 6
Chen, Y., Zeng, X., Gong, X., Chen, Y., Zhang, X., & Luo, S. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.149519 · Cited by 11
Gulyaeva, N. V. (2025) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093025050023 · Cited by 8
“Numerous studies have shown the important role of GLP-1 in protecting against oxidative dam(cid:2) age and activating the Nrf2 signaling pathway [22].”
Ailawadi, S., Murphy, J. E., Storandt, M. H., & Mahipal, A. (2026) · Cancers · doi:10.3390/cancers18020179 · Cited by 11
Fakih, W., Mroueh, A., Kikuchi, S., Marzak, H., Amissi, S., Gong, D.-S., Kerth, S., Kindo, M. J., Mommerot, A., Pieper, M. P., et al. (2026) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2026.101587 · Cited by 7
Genetic Blueprints in Lung Cancer: Foundations for Targeted Therapies
Dan, A., Burtavel, L. M., Coman, M.-C., Focșa, I. O., Duta-Ion, S. G., Juganaru, I. R., Zaruha, A.-G., Strugari, I.-M., Hotinceanu, I. A., Codreanu, P.-C., et al. (2024) · Cancers · doi:10.3390/cancers16234048 · Cited by 8
Chen, W., Yan, X., Song, X., Yang, Y., Wang, X., Xu, G., Wang, T., Liu, Y., Zhao, F., & Song, G. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.12.011 · Cited by 6
Chang, Y., Peng, C.-Y., Chi, K., Song, J., Chang, Y., Chiang, C.-H., Gao, W., & Chiang, C. (2025) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaf017 · Cited by 7
GLP-1/GLP-1RAs: New Options for the Drug Treatment of NAFLD
Jiang, H., & Zang, L. (2024) · Current Pharmaceutical Design · doi:10.2174/0113816128283153231226103218 · Cited by 7
Ibarra-Lara, L., Sánchez‐López, A., del Valle‐Mondragón, L., Soria‐Castro, E., Zarco-Olvera, G., Patlán, M., Guarner‐Lans, V., Torres-Narváez, J. C., Ruiz‐Ramírez, A., de León‐Sánchez, F. D., et al. (2025) · Antioxidants · doi:10.3390/antiox14040482 · Cited by 8
“Phosphorylated Nrf2 (p-Nrf2) accumulates in the nucleus and binds to antioxidant response element (ARE) sites, subsequently activating many genes, including antioxidants, detoxifying enzymes, and transport molecules [12].”
Li, W., & Wang, Y. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1605631 · Cited by 5
“Recent evidence also suggests that GLP-1RAs may activate the NRF2 signaling pathway, leading to upregulation of antioxidant defense genes and attenuation of oxidative stress and in fl ammation (25).”
Arrhythmia-Induced Cardiomyopathy in Atrial Fibrillation: Pathogenesis, Diagnosis, and Treatment
Karakasis, P., Theofilis, P., Vlachakis, P. K., Apostolos, A., Ktenopoulos, N., Grigoriou, K., Patoulias, D., Antoniadis, A. P., & Fragakis, N. (2025) · Life · doi:10.3390/life15111675 · Cited by 9
“Improvements in myocardial fuel handling—greater glucose uptake with more efficient fatty-acid oxidation—mitigate metabolic stress that otherwise promotes fibroblast activation [233], and reinforcement of antioxidant defenses constrains ROS-driven fibrogenesis [234].”
Agu, P. C., Yudas, A. F., & Lu, J. (2025) · Antioxidants · doi:10.3390/antiox14111364 · Cited by 7
GLP-1 Signalling as a Therapeutic Avenue in Parkinson’s Disease: A Comprehensive Review
Orozco, M. P., Rivadeneira, V. V., & León-Rojas, J. E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262412163 · Cited by 8
“GLP-1 signalling activates pathways (such as cAMP/PKA and Nrf2) that boost the expression of antioxidant proteins like superoxide dismutase (SOD), catalase, and glutathione peroxidase [47].”
Kiernan, R., Persand, D., Maddie, N., Cai, W., & Carrillo-Sepúlveda, M. A. (2022) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00031.2022 · Cited by 9
Galetaki, D. M., Cai, C. L., Bhatia, K., Chin, V. L., Aranda, J. V., & Beharry, K. D. A. (2022) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2022.101513 · Cited by 5
Heydarian, D., Flavel, M., Munasinghe, M., Jois, M., & Thomas, J. (2024) · Stresses · doi:10.3390/stresses4040054 · Cited by 5
Elseady, W. S., Ellatif, R. A. A., Estfanous, R. S., Emam, M. N., & Keshk, W. A. (2021) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2021-0183 · Cited by 6
In vitro modeling of the complex retinal condition age-related macular degeneration
Plößl, K., Webster, E., Kiel, C., Graßmann, F., Brandl, C., & Weber, B. H. F. (2022) · Journal of Translational Genetics and Genomics · doi:10.20517/jtgg.2021.39 · Cited by 5
Chen, J., Chuang, M., Lai, H.-W., & Wu, V. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112339 · Cited by 7
Chang, J.-T., Liang, Y., & Leu, J. (2022) · Journal of the Chinese Medical Association · doi:10.1097/jcma.0000000000000844 · Cited by 4
“19 GLP-1 was also reported to have effect in attenuating oxidative damage via Nrf2 signaling 20 and inhibiting AGE-induced upregulation of inflammatory mediators.”
Zein nanoparticles extend lifespan in C. elegans and SAMP8 mice
Martínez‐López, A. L., Reboredo, C., González-Navarro, C. J., Solas, M., Puerta, E., Ramírez, M. J., Vizmanos, J. L., & Irache, J. M. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124798 · Cited by 4
Mirzaei, F., Jalili, C., Khodadadi, I., Hosseini, N. F., Majdoub, N., Naseri, N., Mirzaei, A., & Abbasi, E. (2025) · Biological Trace Element Research · doi:10.1007/s12011-024-04398-9 · Cited by 7
“It has been established that zinc has anti-inflammatory and antioxidant effects, and administration of zinc shows the potential to increase antioxidant enzyme activity (SOD, CAT, and GPx) and reduce MDA levels and inflammation [45].”
Emerging therapeutic landscape: Incretin agonists in chronic kidney disease management
Lian, K., Zhang, K., Kan, C., Hou, N., Han, F., Sun, X., Qiu, H., & Guo, Z. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122801 · Cited by 6
Asemi, Z., Salami, R., Salami, M., Mafi, A., Aarabi, M. H., & Vakili, O. (2022) · Current Molecular Pharmacology · doi:10.2174/1874467215666220829102020 · Cited by 7
Chitosan-Based Nanoformulation as Carriers of Small Molecules for Tissue Regeneration
Narayan, S. (2019) · Springer eBooks · doi:10.1007/978-981-15-0263-7_11 · Cited by 5
Wang, M., Wang, L., Sun, H., Yuan, H., & Li, Y. (2024) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-05118-6 · Cited by 3
“Glucagon-like peptide-1 (GLP-1) is a thirty-one amino acid peptide chain derived from the cleavage of proglucagon, which is produced by L cells located in the gastrointestinal tract [119, 120].”
Effects of the ketogenic diet on skin—potential benefits and risks
Chylińska, N., & Maciejczyk, M. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1686056 · Cited by 4
“Keap1 plays a vital role in regulating the ubiquitination of Nrf2 and, at a later stage, its degradation (19, 123).”
Elliott, B., Tomlinson, E., Desai, N., Heald, A. H., Field, B. C. T., Heiß, C., & Whyte, M. (2026) · Diabetes Therapy · doi:10.1007/s13300-026-01843-x · Cited by 4
“GLP-1 reduces vascular inflammation [7] as well as oxidative stress [8, 17] induced by hyperglycemia in vascular endothelial cells.”
Wang, H.-J., Zhang, L.-B., Sun, S.-P., Yan, Q., Gao, Z., Fu, F., & Qu, M. (2024) · World Journal of Diabetes · doi:10.4239/wjd.v15.i2.287 · Cited by 4
Morsy, M. M., Hassan, H. A., Morsi, R. M., Nafea, O. E., Farag, A. I., & Ramadan, R. S. (2024) · Reproductive Toxicology · doi:10.1016/j.reprotox.2024.108826 · Cited by 3
Romeo, M., Nardo, F. D., Napolitano, C., Basile, C., Palma, C., Vaia, P., Dallio, M., & Federico, A. (2025) · Diabetology · doi:10.3390/diabetology6080079 · Cited by 3
“GLP-1 RAs, currently approved for the treatment of T2DM and obesity, have shown promising hepatoprotective properties [158].”
Viranda, D. P. S., Kurnijasanti, R., Rachmawati, K., Hamid, I. S., Srianto, P., Plumeriastuti, H., & Yustinasari, L. R. (2024) · Ovozoa Journal of Animal Reproduction · doi:10.20473/ovz.v13i1.2024.47-57 · Cited by 3
GLP-1 receptor agonists—another promising therapy for Alport syndrome?
Boeckhaus, J., Mabillard, H. R., & Sayer, J. A. (2025) · Journal of Rare Diseases · doi:10.1007/s44162-024-00065-8 · Cited by 4
“GLP-1 RAs activate the Nrf2 signaling pathway to promote antioxidant defenses [67].”
Oshaghi, E. A. (2017) · Avicenna Journal of Medical Biochemistry · doi:10.15171/ajmb.2017.10 · Cited by 3
Ferri, G., Tesi, M., Pesce, L., Bugliani, M., Grano, F., Occhipinti, M., Suleiman, M., Luca, C. D., Marselli, L., Marchetti, P., et al. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13091403 · Cited by 5
“protection of β-cells against metabolic stresses [8] or against death by increasing autophagic flux and restoring lysosomal function [9].”
BackgroundMethodResultInfluentialWinkler, G. (2021) · Diabetologia Hungarica · doi:10.24121/dh.2021.17 · Cited by 4
Alrasheed, T., Mostafa, M. E. A., Madkhali, M. A., & Khairy, H. A. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1734549 · Cited by 4
“The Nrf2 signaling pathway, a master regulator of cellular antioxidant defense mechanisms, is upregulated by GLP-1 receptor activation, according to preclinical research (49).”
Wang, H. P., Huang, J., Liu, H., Yang, Y., & Hu, J. (2025) · Fishes · doi:10.3390/fishes10110581 · Cited by 2
Sahu, P., Satapathy, A., Satapathy, A., & Satapathy, T. (2025) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-025-10797-w · Cited by 2
“This peptide also modulates key signaling pathways involved in apoptosis and inflammation, contrib - uting to improved cellular resilience under metabolic and oxidative stress conditions (Oh & Jun 2017).”
Braha, A., Timar, B., Sturza, A., & Timar, R. Z. (2026) · Medicina · doi:10.3390/medicina62081509 · Cited by 2
“GLP-1 RAs also boost the body’s own antioxidant defenses by activating nuclear factor erythroid 2-related factor 2 (Nrf2), which increases the levels of antioxidant enzymes like superoxide dismutase (SOD), catalase, and glutathione peroxidase [82–84].”
Geraniin: A Promising Multifunctional Nutraceutical for Diabetes Management
Goh, B. H., & Tan, J. B. L. (2024) · Food Reviews International · doi:10.1080/87559129.2024.2406419 · Cited by 2
“[108,109] Indeed, gallic acid treatment has been reported to markedly increase AMPK expression in the liver, muscle, and interscapular brown adipose tissue (iBAT), as well as strengthen the activity of endogenous antioxidants in the hepatic tissue of diabetic rodents.”
Kartikaningsih, H., Fitriana, N., Anggraeni, I. L., Semedi, B., & Koentjoro, M. P. (2025) · F1000Research · doi:10.12688/f1000research.143708.4 · Cited by 3
“22,41 Under normal circumstances, Nrf2 is bound by the endogenous inhibitor Kelch-like ECH-associated protein 1 (Keap1) in the cytosol.”
Proença, C., Lobo, M. G., Rufino, A. T., de Oliveira, J. M. P. F., Freitas, M., Trepiana, J., Portillo, M. P., Carvalho, F. D., & Fernandes, E. G. R. (2025) · Phytochemistry Reviews · doi:10.1007/s11101-025-10075-z · Cited by 2
“(Oh and Jun 2018).”
Athari, S. Z., Mirzaei, F., Keyhanmanesh, ., Lotfi, H., Sajed, Y., Delkhosh, A., & Ghiasi, R. (2024) · PubMed Central · doi:10.22038/ijbms.2023.70416.15307 · Cited by 4
“…stress exposure, Nrf2 dissociated from inactivated Keap1 (Nrf2 inhibitor) and after phosphorylation, transferred to the nucleus and bound to anti-oxidant responsive element (ARE) sites, which results in the expression of downstream genes such as glutathione peroxidases and heme oxygenase-1 (58).”
BackgroundSrour, L., Ismail, J., Njeim, R., & Eid, A. A. (2024) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-3-031-62131-4_8 · Cited by 2
Alnaser, R. I., Alassaf, F. A., & Abed, M. N. (2025) · World Academy of Sciences Journal · doi:10.3892/wasj.2025.317 · Cited by 1
Šalamun, V., Lovrečić, L., Maver, A., Peterlin, B., Frangež, H. B., Riemma, G., Laganà, A. S., Herman, R., Janež, A., Bokal, E. V., et al. (2025) · Gynecologic and Obstetric Investigation · doi:10.1159/000547513 · Cited by 2
“Liraglutide and other GLP-1 receptor agonists have been shown to reduce oxidative stress by decreasing reactive oxygen species [29].”
Challenging the Dogma: Reversal of End-Stage Liver Fibrosis with Tirzepatide in MASH Cirrhosis
Nguyen, T.-D., Lam-Himlin, D. M., Lizaola‐Mayo, B., & Chascsa, D. M. H. (2025) · Transplantology · doi:10.3390/transplantology6030025 · Cited by 1
“GLP-1 RAs have been found to reduce oxidative stress markers by activating the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway, thereby enhancing cellular antioxidant defenses [17].”
Targeting reactive carbonyls in metabolic disorders
Amaro, A., Freitas, M., & Matafome, P. N. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-27370-4.00022-6 · Cited by 1
Hadid, K. A., Zaki, M., Alassaf, F. A., & Abed, M. N. (2025) · World Academy of Sciences Journal · doi:10.3892/wasj.2025.413 · Cited by 1
“Also, GLP‑1 receptor agonists were suggested to suppress OS generation induced by AGEs‑RAGE and reduce tissue expression of RAGE via activation of cAMP pathways (79).”
Lee, G., Lee, H. Y., Lim, Y. J., Kim, J., Rah, S., Chung, M. J., Park, S. Y., Sa, S., Lee, H., Soh, Y., et al. (2025) · Antioxidants and Redox Signaling · doi:10.1177/15230864251399183 · Cited by 1
“We also examined GLP-1R activation by assessing the phosphorylations of ERK and CREB, which are downstream signaling molecules indicative of GLP-1R activation (Oh and Jun, 2017) (Supplementary Fig.”
Agrawal, N. K., & Phirke, Y. H. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33355-2.00037-2 · Cited by 1
Alenezi, M. A. G., Ewees, M. G., El-Sayed, E. K., Morsy, E. M. E., & Elbaz, M. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05060-y · Cited by 2
“As a DPP-4 inhibitor, alogliptin may confer indirect antioxidant benefits through the elevation of GLP-1 levels, which are known to mitigate oxidative stress and inflammatory responses in various tissues (Oh and Jun 2017).”
The Effects of GLP-1 Receptor Agonists on Retinal Microvascular Alterations
Lampsas, S., Chardalia, G.-M., Agapitou, C., Papastamopoulos, K., Theodossiadis, P., Siasos, G., Oikonomou, E., Lambadiari, V., & Chatziralli, I. (2026) · Biomedicines · doi:10.3390/biomedicines14051057 · Cited by 3
“GLP-1RAs are involved in multiple signaling pathways that contribute to the regulation of endothelial function [20].”
Verma, J., Singh, R. K., Paul, S., Gupta, S., Gupta, A. K., Sharma, A. K., Kumar, M., Mehan, S., Samant, R., & Tongra, M. (2026) · Metabolic Brain Disease · doi:10.1007/s11011-026-01866-0 · Cited by 1
Targeting the GLP-1 receptor pathways for dual management of obesity and depression
Keswani, R., & Bhatt, S. (2026) · Drug Discovery Today · doi:10.1016/j.drudis.2026.104727 · Cited by 2
Güven, C., Taşkın, E., Yumrutaş, Ö., Şener, L. T., Dal, F., Ahbab, M. A., Bozgeyik, İ., Albeniz, İ., Bağış, H., Pehlıvan, M., et al. (2018) · Turkish Journal of Agriculture - Food Science and Technology · doi:10.24925/turjaf.v6i6.792-798.1941 · Cited by 1
Lee, J. S., Chun, H. C., Choi, J. Y., Park, K. S., Chung, S. S., & Park, K. (2023) · Journal of Industrial and Engineering Chemistry · doi:10.1016/j.jiec.2023.07.058 · Cited by 1
Kartikaningsih, H., Fitriana, N., Anggraeni, I. L., Semedi, B., & Koentjoro, M. P. (2024) · F1000Research · doi:10.12688/f1000research.143708.1 · Cited by 1
Ullah, O., Li, Z., Ali, I., Xu, L., Liu, H., & Fang, N. (2018) · Journal of Agricultural Science · doi:10.5539/jas.v10n7p35 · Cited by 1
“NFE2L2 is a transcription factor that regulates intracellular redox balance and antioxidant thus regulates ROS, senescence, and inflammation (Oh & Jun, 2018).”
BackgroundAntioxidant Therapy for High Altitude Sickness and Nano-Medicine
Mudgal, P., & Paliwal, S. (2022) · Springer eBooks · doi:10.1007/978-981-19-1008-1_13 · Cited by 1
Protective effect of lycopene against cytokine-induced β-cell apoptosis in INS-1 cells
Kim, K., Jang, S., Bae, G. D., Jun, H., & Oh, Y. S. (2018) · Journal of Nutrition and Health · doi:10.4163/jnh.2018.51.6.498
“발현을 유도하여 산화스트레스를 감소시키는 역할을 한 다.(23) 그러나 과도한 산화스트레스가 유발되었을 경우, 이 러한 조절시스템의 균형이 깨지면서 세포내 DNA나 단백”
Self-citationSALEH, M. D. S. M. M. S. A., GAFFER, M. D. A. E. M. A. M., & Ewida, S. F. (2020) · The Medical Journal of Cairo University/The Medical Journal of Cairo University · doi:10.21608/mjcu.2020.105131
Reappraisal of Dietary Phytochemicals for Coronavirus Infection: Focus on Hesperidin and Quercetin
Bellavite, P. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.95529 · Cited by 3
Neuroprotective potential of incretinomimetics
Kokin, A. S., Суплотова, Л. А., Сергеевна, Д. Т., & Makarova, O. B. (2023) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2023-159
Zykov, V. A., Крылова, И. Б., Тучина, Т. П., & Galagudza, M. M. (2023) · Regional blood circulation and microcirculation · doi:10.24884/1682-6655-2023-22-2-51-57
Hocaoğlu-Emre, F. S. (2023) · International Conference on Recent Academic Studies · doi:10.59287/as-proceedings.114
Considering the protective effect of exendin-4 against oxidative stress in spiral ganglion neurons.
Wu, H., Ou, Y., Wang, S., Yu, F., Fan, X., Kang, H., & Chen, T. (2023) · PubMed Central · doi:10.22038/ijbms.2023.69190.15076 · Cited by 1
“Studies have shown that GLP-1R agonists can activate the Nrf2/HO-1 pathway and reduce cellular oxidative damage (59, 60).”
BackgroundDiabetes Mellitus'ta Nrf2-Keap1 Aktivasyonu, Antioksidan Savunma Sisteminin Potansiyel Bir Hedefidir
Alı, S. A., Sapmaz, T., Kara, S., & Polat, S. (2024) · Arşiv Kaynak Tarama Dergisi · doi:10.17827/aktd.1435519
Kartikaningsih, H., Fitriana, N., Anggraeni, I. L., Semedi, B., & Koentjoro, M. P. (2024) · F1000Research · doi:10.12688/f1000research.143708.2
Kartikaningsih, H., Fitriana, N., Anggraeni, I. L., Semedi, B., & Koentjoro, M. P. (2024) · F1000Research · doi:10.12688/f1000research.143708.3
Targeting Superoxide to Prevent Diuretic Resistance and Reduce Heart Failure Mortality
Kaesemeyer, W. (2025) · Cardiology in Review · doi:10.1097/crd.0000000000000969
Osuji, E., Wright, J. L., Brar, T., Scott, S. S., & Smith, S. A. (2025) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-3-031-97517-2_6
Metadata
- Authors
- Oh, Y., & Jun, H.-S.
- Affiliations
- Eulji University (KR)
- Gachon University (KR)
- Corresponding author
- Jun, Hee-Sook
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2017-12-22
- Volume
- 19
- Issue
- 1
- Pages
- 26
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC5795977
- OpenAlex
- W2779001901
- Semantic Scholar
- 8fd8d98ecad3afa2039a39b8a6478a9494f9a746
- Cited by
- 217
- References
- 133
- Citations by year
- 2026: 24 · 2025: 50 · 2024: 41 · 2023: 19 · 2022: 21 · 2021: 31 · 2020: 12 · 2019: 9 · 2018: 9 · 2017: 1
- FWCI
- 0.79
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Research Foundation
- Korea Health Industry Development Institute (HI15C0987)
- National Research Foundation of Korea (NRF-2015R1D1A1A01058888)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Keywords
- glucagon-like peptide-1, Nrf2 signaling, Keap1, oxidative stress, antioxidant defense, incretins, GLP-1 receptor agonists, free radicals, cellular stress response, diabetes mellitus
- MeSH terms
- Animals, Diabetes Mellitus, Humans, Nervous System Diseases, Signal Transduction, Reactive Oxygen Species, Oxidative Stress, NF-E2-Related Factor 2, Glucagon-Like Peptide 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.